138 related articles for article (PubMed ID: 37275440)
1. Rates of unanticipated premalignant and malignant lesions at the time of hysterectomy performed for pelvic organ prolapse in an underscreened population.
Barakzai S; Koltun-Baker E; Melville SJF; Rangel E; Dahl M; Dancz CE
AJOG Glob Rep; 2023 May; 3(2):100217. PubMed ID: 37275440
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Pathology Following Vaginal Hysterectomy for Pelvic Organ Prolapse Repair.
Geron Y; From A; Peled Y; Zeevi G; Matot R; Nachshon S; Krissi H
J Womens Health (Larchmt); 2024 May; ():. PubMed ID: 38700374
[No Abstract] [Full Text] [Related]
3. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.
Frick AC; Walters MD; Larkin KS; Barber MD
Am J Obstet Gynecol; 2010 May; 202(5):507.e1-4. PubMed ID: 20452498
[TBL] [Abstract][Full Text] [Related]
4. The incidence and risk factors of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse.
Ryu SM; Cho JS; Kong MK; Bai SW
Int Urogynecol J; 2023 Nov; 34(11):2719-2724. PubMed ID: 37401960
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
Suphattanaporn O; Saraluck A; Mononai J; Lekskul N; Chinthakanan O
Ann Med; 2023; 55(2):2273428. PubMed ID: 37883921
[TBL] [Abstract][Full Text] [Related]
6. Unexpected Significant Uterine Pathological Findings at Vaginal Hysterectomy Despite Unremarkable Preoperative Workup.
Mizrachi Y; Tannus S; Bar J; Sagiv R; Levy T; Condrea A; Ginath S
Isr Med Assoc J; 2017 Oct; 19(10):631-634. PubMed ID: 29103241
[TBL] [Abstract][Full Text] [Related]
7. Vaginal hysterectomy for uterovaginal prolapse: what is the incidence of concurrent gynecological malignancy?
Grigoriadis T; Valla A; Zacharakis D; Protopapas A; Athanasiou S
Int Urogynecol J; 2015 Mar; 26(3):421-5. PubMed ID: 25293812
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of unanticipated pathology in cases of hysterectomy for benign lesion a cross-section study in Al Shifa Medical Complex.
AbuSaqer SM; Shammala AIHA; Elejla S; Mahdi H; Laban RA; Hamada HA; Zimmo MW
Cancer Treat Res Commun; 2023; 35():100697. PubMed ID: 36989579
[TBL] [Abstract][Full Text] [Related]
9. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Occult Uterine Pathology in Women Undergoing Hysterectomy With Pelvic Organ Prolapse Repair.
Ackenbom MF; Giugale LE; Wang Y; Shepherd JP
Female Pelvic Med Reconstr Surg; 2016; 22(5):332-5. PubMed ID: 27171317
[TBL] [Abstract][Full Text] [Related]
11. Impact of surgical training on the performance of proposed quality measures for hysterectomy for pelvic organ prolapse.
Adams-Piper ER; Guaderrama NM; Chen Q; Whitcomb EL
Am J Obstet Gynecol; 2017 Jun; 216(6):588.e1-588.e5. PubMed ID: 28189609
[TBL] [Abstract][Full Text] [Related]
12. Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse.
Hill AJ; Carroll AW; Matthews CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):113-5. PubMed ID: 24566217
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy Versus Hysteropexy at the Time of Native Tissue Pelvic Organ Prolapse Repair: A Cost-Effectiveness Analysis.
Chang OH; Shepherd JP; Ridgeway BM; Cadish LA
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e277-e281. PubMed ID: 32576734
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy and Oophorectomy in Reproductive Age: A Cross-Sectional Study from a Tertiary Care Hospital.
Shahid R; Abbas H; Mumtaz S; Perveen F; Bari MF; Raja T; Memon S; Ahmed N; Dawani K
Cureus; 2020 May; 12(5):e8344. PubMed ID: 32617218
[TBL] [Abstract][Full Text] [Related]
15. Hysterectomy in women with cervical stenosis. Surgical indications and pathology.
Newman C; Finan MA
J Reprod Med; 2003 Sep; 48(9):672-6. PubMed ID: 14562629
[TBL] [Abstract][Full Text] [Related]
16. [Pelvic Reconstruction in Abdominal Trachelectomy and Bilateral Salpingo-Oophorectomy for Occult Uterine Endometrial Cancer Found in Specimens Removed in the Context of Laparoscopic Sacrocolpopexy].
Yoshiyama Y; Obuchi T; Oide S; Oiwa I; Nagae M; Nishio K; Tokiwa S; Matsuura T; Sawada Y; Hayashi T; Otsuka I; Kitagawa Y; Nomura M
Hinyokika Kiyo; 2023 Apr; 69(4):117-120. PubMed ID: 37183043
[TBL] [Abstract][Full Text] [Related]
17. Intention matters: Success rate of bilateral salpingo-oophorectomy at the time of vaginal hysterectomy for pelvic organ prolapse.
Messingschlager C; Ferrando CA; Chang OH
Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():54-58. PubMed ID: 36773471
[TBL] [Abstract][Full Text] [Related]
18. Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction.
Ramm O; Gleason JL; Segal S; Antosh DD; Kenton KS
Int Urogynecol J; 2012 Jul; 23(7):913-7. PubMed ID: 22398824
[TBL] [Abstract][Full Text] [Related]
19. Unanticipated Uterine and Cervical Malignancy in Women Undergoing Hysterectomy for Uterovaginal Prolapse.
Andiman SE; Bui AH; Hardart A; Xu X
Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):e549-e554. PubMed ID: 33208657
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
